Dr karimi

Print
Published on Monday, 11 February 2013

 

Curriculum Vitae

General Data

Name:

Mehran

Surname:

Karimi

Date of birth:

07/23/1965

Place of birth:

Shiraz, Iran

Marital status:

Married

Address:

M. Karimi, MD, Professor of Pediatric Hematology-Oncology

Hematology Research Center,

Pediatrics Department, Nemazee Hospital, Shiraz, Iran.

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. (private e-mail)

Tel: +98 711 6487797 (home number)

Fax: +98 711 6474298

Number of years working experience with hemophilia and thalassemia

15 years

Research interests and plan:

Hemostasis, Thrombosis &Thalassemia

     

Education

2003

Fellowship of Thrombosis, Hemostasis & Thrombosis Research Center Milan-Italy

2001

Training of Haemophilia, Milan Haemophilia Center, Milan - Italy

1996 - 1997

Training of Bone Marrow Transplantation, Saint James Hospital.

Leads, United Kingdom

1994 - 1996

Fellowship in Pediatric Hematology – Oncology, School of Medicine,

Ahvaz University of Medical Sciences, Ahvaz – Iran

1991 - 1993

Residency in Pediatrics, School of Medicine, Shiraz University of Medical Science, Shiraz – Iran

1983 - 1990

Medical School, School of Medicine, Shiraz University of Medical Sciences,

Shiraz – Iran

1979 - 1983

High school, Razi High School, Shiraz – Iran

Licensure

1996

Subspecialty, Pediatric Hematologist – Oncologist, Shiraz – Iran

1993

Specialty, Pediatrics, Shiraz, Iran

1990

M.D. (General Physician), Shiraz, Iran

Academic Activities

2004

Professor of Hematology-Oncology, Hematology research center, School of Medicine, Shiraz University of Medical Sciences, Shiraz – Iran

2000

Associate Professor of Hematology, Hematology research center, School of Medicine, Shiraz University of Medical Sciences, Shiraz – Iran

1996

Assistant Professor of Pediatric Hematology – Oncology, Hematology research center, School of Medicine, Shiraz University of Medical Sciences, Shiraz – Iran

1993

Assistant Professor of Pediatrics, School of Medicine, Shiraz University of Medical Sciences, Shiraz – Iran

Certification

2008

Razi Festival award as a best researcher in Iran

2006

Director of Shiraz Hematology Research Center

2003-2011

Best Researcher in Shiraz University of Medical Sciences

2003

2003                    

Razi Festival award as a best researcher in Iran

Thrombophilia fellowship training

2001

Haemophilia Fellowship Training

1997

Bone Marrow Transplantation Training Certification

1996

Iranian Board of Pediatrics Hematology – Oncology

1993

Iranian Board of Pediatrics

1990

M. D. (General Physician)

Membership

2012                 Member of ASH

2009                      Member of pediatric hematology-oncology board exam

2003

Member of ISTH

2000

Associate Member, Thalassemia International Federation (TIF)

2000

Iranian Pediatric Hematology Society

1999

Director of Fars Hemophilia Society

1998

Fars Thalassemia Control Committee

1998

Director of Fars Thalassemia Society

1997

Director of Fars Iron Deficiency Committee

Presentations:

 

  1. 1.Treatment strategies to prevent/manage thromboembolism in thalassemia and NTDT. EGM Iron Summit. Hong Kong September 2012.
  2. 2.Naderi M, Eshghi P, Cohan N, Karimi M. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  3. 3.Karimi M, Haghpanah S, Ardeshiri R, et al. Socio-cultural challenges of circumcision in patients with hemophilia in Iran. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  4. 4.Beheshtipoor N, Bagheri Sh, Karimi M, et al. The effect of yoga technique on quality of life in Children with hemophilia. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  5. 5.Karimi M, SafarpourM, et al. Genotype and phenotype report on patients with combined deficiency of factor V and factor VIII in Iran. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  6. 6.Karimi M, NasirabadiSh, Mahmoodi M, et al. Phenotypic bleeding penetrance in female carriers of rare inherited coagulation deficiency. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  7. 7.Karimi M, Haghpanah S, Bordbar M, et al. Experience on using prothrombin complex concentrate (PCC) in urgent warfarin reversal: an Iranian survey. XXX International congress of the world federation of Hemophilia. Paris July 2012.
  8. 8.Karimi M, Haghpanah S, Abdolhamid Shariat, et al. Cerebral Artery Velocity in Patients with β-Thalassemia Intermedia Compared to β-Thalassemia Major Using Transcranial Doppler Ultrasonography. ASH Dec. 2012
  9. 9.Savoia A, Kunishima Sh, Karimi M, et al. International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome. ASH Dec. 2012
  10. 10.Napolitano M, Dolce A, Karimi M, et al. Management of the Sponataneous Bleeding Episodes in Factor VII Deficiency. A Prospective Evaluation of the STER. ASH Dec. 2012
  11. 11.Naderi M,Eshghi P, Karimi M, et al. Successful delivery in patients with FXIII deficiency receiving prophylaxis: Report of 17 cases in Iran. ASH Dec. 2012
  12. 12.Karimi M, Vafafar A, HaghpanahS, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. The International Society on Thrombosis and Haemostasis.2011, Japan.

 

 

  1. 13.Menegatti M, Palla R, Karimi M, et al. A RECURRENT P.GLY43ASP SUBSTITUTION OF COAGULATION FACTOR X (FX) IMPAIRS INTRACELLULAR TRAFFICKING AND FUNCTIONAL ACTIVITY CAUSING A SEVERE FX DEFICIENCY IN FOUR PATIENTS. International Society on Thrombosis and Haemostasis.2011, Japan.
  2. 14.Geffen M, Peyvandi F, Menegatti M, Karimi M, et al. RELATION OF BLEEDING TENDENCY IN RARE BLEEDING DISORDERS WITH DEFICIENCIES IN FACTOR II, V, VII, X, XIII, AND FIBRINOGEN AND SIMULTANEOUS THROMBIN AND PLASMIN GENERATION. International Society on Thrombosis and Haemostasis.2011, Japan.
  3. 15.KarimiM, Saki N, SakiF, et al.D-dimer level in pediatric patients with solid and hematologic malignancies, Shiraz, Southern Iran.International Society on Thrombosis and Haemostasis.2011, Japan.
  4. 16.KarimiM, HaghpanahS. Cerebral thromboembolic events in patients with beta-thalassemia: a systematic-review. International Society on Thrombosis and Haemostasis.2011, Japan.
  5. 17.KarimiM. Long term effects of hypoparathyroidism in thalassemia. The First Qatar Thalassemia Forum On Growth and Endocrine Complications of Thalassemia & The First Meeting of The International Group For Studying Endocrine Complications of Thalassemia (I-CET). Oct.2011, Qatar.
  6. 18.KarimiM. Growth and development. Thalassemia Iron Summit. Apr.2011, Dubai.
  7. 19.KarimiM. Experince with chelation therapy in Iran. Thalassemia Iron Summit. Apr.2011, Dubai.
  8. 20.KarimiM. Use of Exjade in iron chelation therapy: multi-center Iran experience. Exjade Copy Advisory Board. Sep.2011, Dubai.
  9. 21.KarimiM. Use of Iron chelation in malignancy Clinical Case 6: Presentation and Discussion. Exjade Copy Advisory Board. Sep.2011, Dubai.
  10. 22.Karimi M, Dehghani J, Afrasiabi AR., et al. Correlation Between Mean Corpuscular Volume and Mean Corpuscular Hemoglobin With Beta Thalassemia Mutations in Southern Iran. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  11. 23.Yavarian M, Mahdavi MR, Karimi M, Roshan P, et al. Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic? 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  12. 24. Dehbozorgian J, Imanifard J, Dehghani J, Karimi M, et al. Diagnostic Problem in Combined HB H Disease and Heterozygote Beta thalassemia. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  13. 25. Musallam K, Karimi M, et al. A Closer Look at Pulmonary Hypertension Risk in Patients with Thalassemia Intermedia. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  14. 26.Dehghani J, Karimi M, Afrasiabi AR., et al. Correlation between HBA2 with Beta Thalassemia Mutations in Southern Iran. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  15. 27.Afrasiabi AR., Karimi M, Dehghani J, et al. Beta Thalassemia Screening through Prenatal Diagnosis in Southern Iran, A Cohort Study. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  16. 28. Javanmardi E, Dehghani J, Karimi M, et al. Correlation of C36-37 Mutation of β Globin Gene With Informative Sites In Haplotype Analysis, In Southern Iran. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  17. 29.Zahedi Z, Karimi M, Beheshtipoor N. Comparative survey in anxiety level in employed and unemployed patients with major beta thalassemia in Iran.12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  18. 30.Zahedi Z, Karimi M. Quality of life in married patients with beta thalassemia in Iran. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  19. 31.Karimi M, Haghpanah S, Yavarian M, et al. Long term use of hydroxyurea in patients with β-thalassemia in southern Iran. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  20. 32.Karimi M, Haghpanah S. Cerebral thrombosis in patients with beta-thalassemia: a mini-review. 12th International conference on thalassemia & haemoglobinopathies and 14th International TIF Conference for patients & parents. 11-147 May 2011, Turkey.
  21. 33.Karimi M, Mehramiri A. Attitudes of haemophilic patients about their health and socio-economic problems in Iran. EAHAD 4th Annual Congress 2011, Vol 17.
  22. 34.Karimi M. How to prepare and support affected women to deal with the medical condition in Iran. The 4th International Symposium on Womens's Health Issue in Thrombosis and Haemostasis 2011, Vol 127, suppl 3.
  23. 35.Amooee S, Samsami A, Jahanbakhsh J, Karimi M. The pregnancy outcome in patients with minor b-thalassemia. The 4th International Symposium on Womens's Health Issue in Thrombosis and Haemostasis 2011, Vol 127, suppl 3.
  24. 36.Karimi M. Unusual extramedullar hematopoiesis presentation as a left temporal mass in a patient with blood transfusion dependent beta-thalassemia. 3rd Hematology Oncology Summit 2011.
  25. 37.Karimi M, Yavarian M, Afrasiabi A, Ramzi M, et al. The impact of Prothrombin 20210A polymorphism and factor V Leiden on deep vein thrombosis in the south Iranian patients.21st International congress on thrombosis 2010, vol 37, suppl 1.
  26. 38.Taher A, Musallam K, Karimi M, et al. Risk facors for venous thromboemblic Events in splectonomized patients with thalassemia Intermedia .21st International congress on thrombosis 2010, vol 37, suppl 1.
  27. 39.Afrasiabi A, Karimi M, Artoni A, et al. Normal delivery of a known Bernard soulier syndrome case, with massive bleeding which controlled by RFVII. 21st International congress on thrombosis 2010, vol 37, suppl 1.
  28. 40.Karimi M, Rezaeifarid, M. Bone mineral density in Iranian hemophilic patients: the first experience in the south of Iran. XXIXth International congress of the world federation of Hemophilia 2010, vol 16, suppl 4.
  29. 41.Haghpanah S, Vafafar M, Karimi M, et al. Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction. XXIXth International congress of the world federation of Hemophilia 2010, vol 16, suppl 4.
  30. 42.Rezazadeh S, Haghighat A, Karimi M, et al. Evaluation of intra articular rifampicin in reducing pain, hemarthrosis and improving joint motions in hemophilic arthropathy. XXIXth International congress of the world federation of Hemophilia 2010, vol 16, suppl 4.
  31. 43.Beheshipoor N, Karimi M, et al. Evaluation of Sports and exercises in patientshemophilia. XXIXth International congress of the world federation of Hemophilia 2010, vol 16, suppl 4.
  32. 44.Karimi M, Afrasiabi A, Beheshtipoor N, et al. Frequency, clinical manifestations and management of rare bleeding disorders in Fars province, Southern Iran. XXIXth International congress of the world federation of Hemophilia 2010, vol 16, suppl 4.
  33. 45.Karimi M. Supporting women affected by congenital bleeding disorders in Iran. XXIXth International congress of the world federation of Hemophilia July 2010.
  34. 46.Karimi M, Bordbar MR, Zareifar S, Hamidi R, Mehravar Z. Unusual presentation of T-cell non-hodgkin lymphoma with multiple skin nodules. 6th Congress of the SIOP Asia. Iran-Kish Island. IJBC, Vol 2, Suppl 1, March 2010
  35. 47.Bordbar MR, Shahriari M, Karimi M. Leukemic infiltration of the appendix as an unusual site of extramedulary relapse report of two cases and review of the literature. 6th Congress of the SIOP Asia. Iran-Kish Island. IJBC, Vol 2, Suppl 1, March 2010
  36. 48.Karimi M. Dialameh Z, Haghighat M. Study of protective effect of breast feeding against lymphoma and leukemia in childhood. 6th Congress of the SIOP Asia. Iran-Kish Island. IJBC, Vol 2, Suppl 1, March 2010
  37. 49.Karimi M, Azarkeivan A, Hoofar H, Eslami M. Malignancies in patients with B-thalassemia major and B-thalassemia intermedia: A multicenter study in Iran. 6th Congress of the SIOP Asia. Iran-Kish Island. IJBC, Vol 2, Suppl 1, March 2010
  38. 50.Zekavat OR, Samani SM, Nasibi S, Karimi M. Clinical evaluation of the new topical An-esthetic formulation in β-thalassemia major patients. The Journal of Applied Resaerch. Vol. 9. No. 3, 2009
  39. 51.Yavarian M, Karimi S, Ahmadian L, Karimi M, et al. Frequency of factor V leiden and prothrombin 20210A as thrombotic and genetic risk factors for preeclampsia in the South Iranina provice. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  40. 52.Karimi M, Pourmohamadi K, Bastani P. Quality of life in hemophilia complicated by inhibitors. XXII Congress. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  41. 53.Karimi M, Cohan N, Yavarian M, Ardeshiri Y, et al. Frequency of intracranial hemorrhage among Iranian patients with rare bleeding disorders. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  42. 54.Karimi M, Yavarian M, Ramzi M, Zakernia M, et al. Frequency of hereditary thrombophilic risk factors in Iranian patients with deep vein thrombosis. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  43. 55.Karimi M, Ahmadkia daliri A, Pourmohammadi K, Bastani P. The impact of inhibitors on the cost of clotting factor replacement therapy in hemophilia A in South of Iran. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  44. 56.Karimi M, Cohan N, Ardeshiri Y, Beheshtipoor N, et al. Frequency of menorrhagia among Iranian women with rare bleeding disorders. XXII Congress. The International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, Vol 7, Suppl 2
  45. 57.Karimi M, Amoei S, Zolghadri J, Afrasiabi A. Survey of coagulation disorders in women with idiopathic menorrhagia. 3rd International Symposium on Women’s Health Issues in Thrombosis and Haemostasis. February 6-8, 2009, Prague, Czech Republic.
  46. 58.Karimi M, Zolghadri J, Nesam M, Afrasiabi A. Inhterited thrombophilia and recurrent pregnancy loss. 3rd International Symposium on Women’s Health Issues in Thrombosis and Haemostasis. February 6-8, 2009, Prague, Czech Republic.
  47. 59.Karimi M, Emad Marvasti V, Afrasiabi A, Safaei Jahromi F. The hematological, adverse effects and clinical responses of beta-thalassemia intermedia patients to hydroxyurea: 10 years experience in Iran. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  48. 60.Karimi M, Emad Marvasti V, Karamifar H, Khabiri M, Jabbarian A, Safaei Jahromi F. Gynecomastia in thalassemia major adolescent boys. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  49. 61.Karimi M, Emad Marvasti V, Mehrabnejad S, Mohagheghi P, Afrasiabi A, Dehbozorgian J. Prevalence of delta beta thalassemia in Southern Iran. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  50. 62.Karimi M, Emad Marvasti V, Riahi Alam M, Hoseini J, Shoja L. Major cause of hospital admissions in major thalassemia patients during 2005-2008. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  51. 63.Karimi M, Emad Marvasti V, Moshiri A, Rasekhi A, Kumar PV, Safaei Jahromi F. Magnetic resonance imaging (MRI) evaluation of liver iron concentration in patients with beta-thalassemia major. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  52. 64.Karimi M, Emad Marvasti V, Moshiri A, Rasekhi A, Kumar PV, Safaei Jahromi F. Magnetic resonance imaging (MRI) evaluation of liver iron concentration in patients with beta-thalassemia major. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  53. 65.Karimi M, Fotouhi Ghiam A, Hashemi A, Afrasiabi A. Thalassemia minor is not a risk factor for suicide, impulsivity and aggression: a reverse approach. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  54. 66.Afrasiabi A, Karimi M, Shahriari M, et al. Beta globin's single nucleotide polymorphisms frequency in beta thalassemia carrier in south of Iran. International Thalassemia Conference. 11th international conference on thalassemia & haemoglobinopathies and 13th International TIF Conference for thalassemia patients & parents. 8-11 October 2008, Singapore.
  55. 67.Karimi M, Shafieian R. Prophylactic effect of recombinant factor VIIa in two patients with congenital factor VII deficiency. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  56. 68.Karimi M, Afrasiabi A, Peyvandi F, Margalione M, Garagiola I, Nasirabadi S. Carrier detection and prenatal diagnosis in high risk families. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  57. 69.Karimi M, Amirhakimi A, Afrasiabi A, Beheshtipoor N, Ardeshiri R. Evaluation of annual coagulation disorders in south Iran: 6 years experience. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  58. 70.Karimi M, Afrasiabi A, Beheshtipoor N, Ardeshiri R, Dehbozorgian J, Yavarian M. An overview to hemophilia inhibitor patients in southern Iran. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  59. 71.Menegatti M, Karimi M, Afrasiabi A, Peyvandi F. Report on ten new patients with congenital factor X deficiency and the associated mutations. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  60. 72.Menegatti M, Spreafico M, Karimi M, Shetty S, Srivastava A, Peyvandi F. Prevalence of gain-of-function factor V leiden and prothrombin G20210A in a large cohort of patietns with rare bleeding disorders. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  61. 73.Beheshtipoor N, Karimi M. The effect of self infusion and self care on referring to hospital in hemophilic patients. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  62. 74.Beheshtipoor N, Haghnegahdar A, Karimi M, Ardeshiri R. Violence by husbands among mothers of children with hemophilia. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  63. 75.Beheshtipoor N, Haghnegahdar A, Karimi M. Guidelines for communication with hemophilia adolescent patients. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  64. 76.Karimi M, Afrasiabi A. Amoei S, Nasirabadi S, Zolghadri J. Survery of coagulation disorders in woment with idiopathic menorrhagia. Istanbul, Turkey June 1-5, Volume 14, Supplement 2, 2008
  65. 77.Karimi M. Alternative medical treatment of AUB in women with coagulation disorders. The 1st Iranian Seminar of Thrombosis & Homeostasis with considering obstetric & gynecologic complications. Mashhad, Iran, May 14-15, 2008.
  66. 78.Karimi M. Hereditary Thrombophilia. The 1st Iranian Seminar of Thrombosis & Homeostasis with considering obstetric & gynecologic complications. Mashhad, Iran, May 14-15, 2008
  67. 79.Karimi M. Prophylactic effect of rFVIIa in two newborns with severe factor VII deficiencies using port-a-cath. 9th Novo Nordisk symposium on Haemostasis management. 14-16 Nov. 2007, Barcelona, Spain.
  68. 80.Derakhshan A, Karimi M, Ghadimi Moghadam A, Basiratnia M. Comparative evaluation of renal findings in thalassemia major and thalassemia intermedia in children and young adults. 14th congress of the International Pediatric Nephrology Association IPNA. 31 August – 4 September, 2007 Budapest, Hungary
  69. 81.Karimi M, Afrasiabi R, Zolghadri Z, Samsami Z, Dehbozorgian J, Yavarian M. Influence of inherited thrombophilia with recurrent pregnancy loss. XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  70. 82.Spreafico M, Menegatti M, Garagiola I, Palla R, Tagliabue L, Karimi M, Lak M. et al. Database on rare bleeding disorder (RBDS): phenotype and genotype analysis on 400 affected patients. XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  71. 83.Karimi M, Pishva N, Shahbazi M, Afrasiabi A, Jamalian N. Determination of protein C level in neonates with sepsis like illness. XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  72. 84.Karimi M, Jafari H, Akbari A, Afrasiabi A, Dehbozorgian J, Ardeshiri R. Factor XI deficiency in Southern Iran and review of literature. XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  73. 85.Artoni A, Afrasiabi A, Lecchi A, Karimi M, Ashouri E, et al. Genetic characterization of patients with Bernard-Soulier Syndrome and their relatives from Southern Iran. XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  74. 86.Menegatti M, Palla R. Afrasiabi A, Karimi M, De Cristofaro R, et al. Kinetics studies of a naturally occurring mutation on factor X (FX) Gene (G222D). XXIst Congress of the International Society on Thrombosis and Haemostasis. 53rd Annual SSC Meeting. 6-12 July 2007, Geneva- Switzerland
  75. 87.Afrasiabi AR, Karimi M, Rahiminezhad MS, Dehbozorgian J, Yavarian M, Akbari A, et al. Prenatal diagnosis of Beta-Thalassemia in the South of Iran. 4th Congress of Iranian Pediatric Hematology and Oncology Society. 7-9 September 2006, Kerman, Iran.
  76. 88.Dehbozorgian J, Karimi M, Afrasiabi AR, Yavarian M, Badiefard L, Akbari A, et al. The importance of differential diagnosis of alpha-thalassemia in prenatal diagnosis. 4th Congress of Iranian Pediatric Hematology and Oncology Society. 7-9 September 2006, Kerman, Iran.
  77. 89.Karimi M, Moosavizadeh K, Falahi MJ. Adverse effects of hydroxyurea in Beta-thalassemia intermedia patients: 8 years experience and review of literature. 4th Congress of Iranian Pediatric Hematology and Oncology Society. 7-9 September 2006, Kerman, Iran.
  78. 90.Imanieh MH, Akbari A, Karimi M. Prevalence of HCV antibody positivity in multitransfused thalassemic patients Dastgheib Hospital, Shiraz-Iran. 4th Congress of Iranian Pediatric Hematology and Oncology Society. 7-9 September 2006, Kerman, Iran.
  79. 91.Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaei A, Saadat M. Frequency of apolipoprotein E alleles in healthy population of Iranian thalassemia patients. 14th National & 2nd International Conference of Biology Tarbiat Modares University, Tehran, Iran 2006
  80. 92.Karimi M, Lak M, Afrasiabi A, Zangneh H, Mannucci P, Peyvandi F. Arg77His: a common mutation of factor XIII deficiency in Iran. Haemophilia Word Congress. 21-25 May 2006, Vancouver, Canada.
  81. 93.Beheshtipoor N, Karimi M. Home treatment in Iranian patients with hemophilia. 21-25 May 2006, Vancouver, Canada.
  82. 94.Eshghi P, Jazebi M, Hoorfar H, Karimi M, et al. Multicentric screening of factor VIII inhibitor in 355 hemophilia A patients in Iran 2005. 21-25 May 2006, Vancouver, Canada.
  83. 95.Afrasiabi A, Lecchi A, Karimi M, Ashouri E, et al. Clinical, biological and genetic characterization of a cohort of patients with Bernard-Soulier syndrome in South Iran. 21-25 May 2006, Vancouver, Canada.
  84. 96.Monaldini L, Duga S, Asselta R, Peyvandi F, Karimi M, et al. Two novel homozygous mutations in the fibrinogen genes identified in two Iranian afibrinogenemic patients. 21-25 May 2006, Vancouver, Canada.
  85. 97.Rahmanian S. Karimi M, Zangeneh H, Pasalar M. Health vs. cost assessment in Iranian hemophiliac patients. 21-25 May 2006, Vancouver, Canada.
  86. 98.Karimi M, Afrasiabi A, Zangeneh H, Dehbozorgi J, et al. Von willebrand disease, a modifier of bleeding in FXI deficiency. 21-25 May 2006, Vancouver, Canada.
  87. 99.Karimi M, Marvasti VE, Motazedian S, Sharifian M. Is b thalassemia trait a protective factor against hypertension in young adults? 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

100.Karimi M, Nikrooz P, Kashef S, Davatolhagh Z. Survey on RBC alloimmunization in blood transfusion dependent beta-thalassemia major patients in Iran, 2004. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

101.Karimi M, Kazeroni T, Jabarian A, Eghlidi MS, Karamizadeh Z. Evaluation of the prevalence of ovarian cysts in girls above fourteen years old with major thalassemia in Southern Iran, 2004. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

102.Karimi M, Karamifar H, Sobhani N. Insulin-like growth factor-1 in b thalassemia minor children. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

103.Karimi M, Afrasiabi A, Dehbozorgian J, Shahcheraghi F, et al. Long term follow up of ferritin level in H.C.V. sero positive transfusion dependent thalassemia patients.

104.Karimi M, Khanlari M. Cerebrovascular accident in b-thalassemia major (B-TM) and intermedia (B-TI). 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

105.Bazrgar M, Peiravian F, Fathzadeh M, Karimi M. Left ventricular dysfunction in b-thalassemia major: A correlation study between hematological parameters and iron chelation with echocardiographic findings. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

106.Karimi M, Marvasti VE, Motazedian S, Sharifian M. Is b-thalassemia trait a protective factor against hypertension in young adults? 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

107.Johari Sh, Karimi M. Socloeconomical and cultural factors affecting family planning among families of thalassemic children in Southern Iran. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

108.Marvasti VE, Karimi M. Is b-thalassemia trait a risk factor for developing depression in young adults? 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

109.Karimi M, Afrasiabi A, Askarinejad A, Ashrafi A. A study on the prevention and decline of thalassemia through increase awareness and family planning. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

110.Afrasiabi A, Karimi M, Zeinali S, Dehbozorgian J, et al. Prevalence of beta-gene mutations in South of Iran. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

111.Afrasiabi A, Karimi M, Dehbozorgian J, et al. Molecular prenatal diagnosis in South of Iran. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

112.Afrasiabi A, Karimi M, Zeinali S, et al. Prevalence of beta-gene mutations in South of Iran. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

113.Dehbozorgian J, Karimi M, Badieefar L, et al. Experience of a/b chain biosynthesis and application in premarital screening. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

114.Karimi M, Ashrafi A, Askarnejad A, et al. Screening program of beta-thalassemia and the reasons of new cases in Southern Iran. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

115.Karimi M, Fotuhi A, Hashemi, et al. Bone mineral density in beta-thalassemia major and intermedia. 10th International Conference on Thalassemia & Haemoglobinopathies & 12th International TIF Conference for Thalassemia Patients and Parents. 7-10 January 2006, Dubai, UAE.

116.Imanieh MH, Karimi M, Jahaniar Moqadam F, Mowla A. Comparison of amantadine plus interferon-a versus interferon-a alone in the treatment of hepatitis C infection in b-thalassemia major patients in Shiraz, Iran. International Saudi Symposium of Pediatric Hematology/Oncology. 21-23 November 2005, Jadeh, Saudi Arabia.

117.Karimi M, Shadmanie A, Shadmanie Gh, Safaei Jahromi F. Survival analysis and factors affecting survival in 0-18 year old patients with hematogenous malignancies who referred to South of Iran between 1991-2003. International Saudi Symposium of Pediatric Hematology/Oncology. 21-23 November 2005, Jadeh, Saudi Arabia.

118.Safaei Jahromi F, Ayatollahi M, Ramzi M, Entezam M, Karimi M. Survey of anticardiolipin antibodies in childhood acute lymphoblastic leukemia: Prevalence and clinical significance. International Saudi Symposium of Pediatric Hematology/Oncology. 21-23 November 2005, Jadeh, Saudi Arabia.

119.Ayatollahi M, Ramzi M, Karimi M, Entezam M. Anticardiolipin antibodies in adult and childhood acute leukemia. International Saudi Symposium of Pediatric Hematology/Oncology. 21-23 November 2005, Jadeh, Saudi Arabia.

120.Alireza Fotouhi Ghiam, Mohammad Hadi Imanieh, Zahra Hashemi, Mehran Karimi. Investigation of helicobacter pylori infection in beta-thalassemia major patients with recurrent abdominal pain. Turkish Journal of Hematology, xxxth World Congress of the International Society of Hematology. Sup Vol. 22, 28 Sep. - 2 Oct. 2005, Istanbul, Turkey.

121.Alireza Fotouhi Ghiam, Alireza Hashemi, Mehran Karimi, Saied Alinejad, et al. Bone mineral density in beta-thalassemia major and intermedia. Turkish Journal of Hematology, xxxth World Congress of the International Society of Hematology. 28 Sep.- 2 Oct. 2005, Istanbul, Turkey.

122.Alireza Hashemi, Alireza Fotouhi Ghiam, Soudabeh Sadeghi Jahromi, Shahin Toobaee, Mehran Karimi. Substance abuse in Iranian patients with haemophilia. Turkish Journal of Hematology, xxxth World Congress of the International Society of Hematology. 28 Sep.- 2 Oct. 2005, Istanbul, Turkey.

123.Mehran Karimi. The hematological and clinical responses of thalassemia intermedia patients to hydroxyurea during a 7 years therapy in Iran. The 4th middle East Thalassemia Investigators and Thought Leaders Meeting. 30 Sep. 2005, Esma Sultan, Istanbul, Turkey.

124.Mehran Karimi. Developing hemophilia care programs. The World Federation of Hemophilia’s. 9th Musculoskeletal Congress. 9-11 Sep. 2005, Istanbul, Turkey.

125.Karimi M. Evaluation of child thrombotic disorders and approach to it. 5th National Iranian Congress of Hematology, Oncology & Nursing. 22-24 June 2005, Shiraz, Iran.

126.Karimi M., Ayatollahi M, Ramzi M, Aghdaie M. Survery of anticardiolipin antibodies in childhood acute lymphoblastic leukemia: Prevalence and Clinical Significance. 5th National Iranian Congress of Hematology, Oncology & Nursing. 22-24 June 2005, Shiraz, Iran.

127.Karimi M., Amipour A., Hashemi A., Fotouhi Ghiam A, Doroudchi M., Ghaderi A.. Survey of anti-viral antibodies in acute childhood leukemia. 5th National Iranian Congress of Hematology, Oncology & Nursing. 22-24 June 2005, Shiraz, Iran.

128.Karimi M. Successful control of central nervous system (CNS) bleeding in 2 newborns with severe factor VII deficiency using rFVIIa administered via port-a-Cath. 8th Novo Nordisk Symposium on Haemostasis Management. 11-13 May 2005, Copenhagen, Denmark.

129.Ayatollahi M, Ramzi M, Karimi M, Entezam M, et al. Anticardiolipin antibodies in patients with some haematological malignancies. The 3rd Regional Conference of Asian Pacific Organization for Cancer prevention (APOCP). GI Cancer Control. 25-27 April 2005, Zibakenar, Rasht, Iran.

130.Karimi M., Dehghani M., Ardeshiri R. and Jahromi FS. Mortality rate among hemophilia in Southern of Iran: 20 years follow-up. World Federation Hemophilia Congress. 17-21 Oct 2004, Bangkok, Thailand.

131.Karimi M., Karegar M., Ardeshiri R. and Beheshtipoor N. Prevalence of inhibitors among hemophilia patients in Southern part of Iran. World Federation Hemophilia Congress. 17-21 Oct 2004, Bangkok, Thailand.

132.Peyvandi F., Menegatti M., Kavakli K., Karimi M. and Mannucci PM. Molecular evaluation of a naturally occurring mutation on factor X gene (Gly 222 Asp) causing severe FX deficiency. World Federation Hemophilia Congress. 17-21 Oct 2004, Bangkok, Thailand.

133.Beheshtipoor N., Karimi M. The effect of self treatment education on referring hemophilia patients to hospital. World Federation Hemophilia Congress. 17-21 Oct 2004, Bangkok, Thailand.

134.Mowla A., Karimi M., Afrasiabi A.R. Glucose tolerance test in major thalassemic patients with and without hepatitis C virus infection; An experience in Southern Iran. 4th National Iranian Congress of Hematology & Oncology and Nursing Meetikng, 23-25 June 2004, Mashhad, Iran.

135.Karimi M., Yarmammady H. Analysis of intelligence quotient in patients with homozygous beta-thalassemia in Shiraz, Iran. 9th congress of the European Hematology Association. 10-13 June 2004, Geneva, Switzerland.

136.Rahimi Z., Merat A., Haghshenass M., Karimi M., et al. XMN I site polymorphism 5’ to gama G in sickle cell disease in Southern Iran. 9th congress of the European Hematology Association. 10-13 June 2004, Geneva, Switzerland.

137.Mohammad Amin Kashef, Sara Kashef, Farhad Hanjani, Mehran Karimi, et al. Hodgkin’s lymphoma developing in a 4.5 year-old girl with hyper-IgE syndrome. The Australian Health & Medical Research Congress 2004, Australia.

138.Karimi M., Habibzadeh F., De Sanctis V. Hypoparathyroidism with Extensive intracerebral calcification in patients with b-thalassemia major. 2nd Conference of Iranian Pediatric Hematology and Oncology Society. 28-30 April 2004, Kish, Iran.

139.Beheshtipoor N., Karimi M. Carrier detection and fetal diagnosis in hemophilia. 2nd congress of preventive non-contiguous diseases. 7-9 Mar. 2004, Tehran, Iran,

140.Beheshtipoor N., Haghnegahdar A., Karimi M. Cardiac complications in b-thalassemia major patients in Shiraz-Iran. 2nd congress of preventive non-contiguous diseases. 7-9 Mar. 2004, Tehran, Iran.

141.Beheshtipoor N., Karimi M. Carrier detection and fetal diagnosis in b-thalassemia major. 2nd congress of preventive non-contiguous diseases. 7-9 Mar. 2004, Tehran, Iran.

142.Karimi M., Karamifar H. Short stature in b-thalassemia minor subjects. 45th Annual meeting of the ASH. 6-9 Dec. 2003, Sandiago, USA.

143.Karimi M., Yarmohammadi H., Safaei Jahromi F. Common and uncommon presentations of childhood leukemia and lymphoma: A five-year analysis of 367 patients in a large referral center in Iran. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

144.Yarmohammadi H., Safaei Jahromi F., Karimi M. Incidence of cancer in children of Fars province: A 10-year descriptive epidemiological study. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

145.Alavi M., Nabavizadeh A., Mowla A., Karimi M. The role of whole body bone scan in acute lymphoblastic leukemia. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

146.Rasekhi AR., Mojarrab M., Afrasiabi R., Karimi M. Neuroblastoma: Epidemiological study of signs and symptoms and staging: 1992-2001. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

147.Asadi-Pooya AA., Karamizadeh Z., Rahiminejad MS., Shahriari M., Kraimi M. Disturbances in calcium metabolism in childhood lymphoblastic leukemia, before and after chemotherapy. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

148.Pishva N., Karimi M. A pilot study on hemoglobinopathy in neonates with indirect hyperbilirubinemia in Nemazee Hospital, Shiraz-Iran. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

149.Cheriki S., Alborzi A., Karimi M., Oboodi B. The incidence of bacterial infections in neutropenic patients aged < 15 years admitted to Shiraz University Hospitals: 1379-80. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

150.Zakerinia M., Karimi M., Nourani Khojasteh H., Ramzi M., Haghshenas M., Ejaz Ahmad. Successful treatment of cyclophasphomide induced intractable hemorrhagic cystitis with novoseven (Factor VII Activated) after allogeneic bone marrow transplantation. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

151.Peiravian F., Sharifkazemi MB, Shojaee E., Karimi M., Samim MM. Role of ECG holter monitoring in early detection of occult arrhythmia in thalassemia major. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

152. Asadi-Pooya AA., Karamizadeh Z., Bagheri M.H., Rasekhi A.R., Karimi M., Shahriari M., Rahiminejad M.S. Radiographic findings in childhood lymphoblastic leukemia. 16th international congress of geographic medicine advances in basic and clinical oncology. 1-4 December 2003, Shiraz, Iran.

153.Alborzi A., Karimi M., et al. The incidence of bacterial infections in neutropenic patients (Age <15 years) admitted in Shiraz University Hospitals (2000-2001). 2nd International Young Medics Conference, 26-28 Sept. 2003, Armenestan.  

154.Garagiola I., Peyvandi F., Karimi M., Lavoretano S., Mannucci P., Fondazione L. Molecular characterisation of vascular endothelial growth factor (VEGF) gene and evaluation of VEGF plasma levels in patients post myocardial infarction with and without collateral blood vessels. 8th Annual Congress of the European Hematology Association. 12-15 June 2003, Lyon, France.

155. Menegatti M., Garagiola I., Karimi M., Peyvandi F. Bleeding symptoms in patients with combined FVII+FX deficiency. 8th Annual Congress of the European Hematology Association. 12-15 June 2003, Lyon, France.

156. Karimi M., Johari Sh. Investigation of acceptance of PND (Prenatal Diagnosis) and abortion of thalassemia affected fetus among thalassemics over 16 years of age and parents of disease children. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

157. Karimi M., Nica Cappellini M., Castelli R. Extramedullary haematopoiesis in Iranian thalassemia intermedia patients: report of two cases. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

158. Karimi M. Evaluation of efficacy of instruction among beta thalassemia major patients in Shiraz – Iran. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

159. Yavarian M, Karimi M, Harteveld C, et al: Response to hydroxyurea treatment in b-thalassemia intermedia patients in South-Iran. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

160. Zarbakhsh B., Zeinali S., Karimi M., Mohammadi M.S., et al: a- Thalassemia Genotypes in Iran. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

161. Afrasiabi A, Dehbozorgian J, Asadzadeh R, Karimi M, et al: Compare of M.C.V with Beta gene point mutation. The 9th International Conference on Thalassemia and Hemoglobinopathies. Terrasini. 15-19 October 2003, Palermo, Italy.

  1. 162. M. Karimi, PM. Mannucci, A. Mosalaei, et al. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). XIX Congress of the International Society on thrombosis and haemostasis. 12- 18 July 2003, Birmingham, UK.

163. M. Karimi, M. S. Rahiminejad, T. Karamimagham. Coagulation disorders in beta-thalassemic patients in Southern Iran. XIX Congress of the International Society on thrombosis and haemostasis 12- 18 July 2003, Birmingham, UK.

164. M. Karimi, H. Yarmohammadi, R. Ardeshiri, et al. Inherited coagulation disorders in Southern Iran. XIX Congress of the International Society on thrombosis and haemostasis 12- 18 July 2003, Birmingham, UK.

  1. 165. J. Shenoi, M. Karimi, C. Ross, et al. The three I Hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH. XIX Congress of the International Society on thrombosis and haemostasis 12- 18 July 2003, Birmingham, UK.
  2. 166. M. S. Enayat, B. D. M. Theophilus, S. Farjadian, M. Karimi, et al. Identification of factor IX mutations in 17 Iranian families with hemophilia B. XIX Congress of the International Society on thrombosis and haemostasis 12- 18 July 2003, Birmingham, UK.
  3. 167. M. Karimipour, S. Zeinali, M. Lak, R. Safaie, N. Nafissi, M. Karimi. Rapid screening of factor IX mutations by SSCP and sequencing in 50 Iranian families. XIX Congress of the International Society on thrombosis and haemostasis 12- 18 July 2003, Birmingham, UK.
  4. 168. Karimi M. Evaluation of efficacy of instruction among Beta-thalassemia major patients in Shiraz- Iran. 15th international congress of Geographic Medicine and National Congress of Medical Education. 9-11 December 2002, Shiraz, Iran.
  5. 169. Karimi M, et al. Epidemiologic and survival rate of childhood rhabdomyosarcoma in Southern Iran. An International symposium of Cancer. 14-16 Oct. 2002, Riadh, Kingdom of Saudi Arabia.
  6. 170. Karimi M, Soltani M. Evaluation of local anesthetic EMLA ointment among childhood malignancy. First International Congress of Anesthesiology and Perioperative Medicine. 2-5 Oct. 2002, Shiraz-Iran.
  7. 171. Karimi M, Yarmohammadi H: Seasonal variations in the onset of childhood leukemia / lymphoma.18th UICC international cancer congress, 30 June – 5 July 2002; Oslo, Norway.
  8. 172. Karimi M, Marthinez di Montemuros F, Danielli MG, et al: Molecular characterization of glucose – 6- phosphate dehydrogenase (G6PD) deficiency in Iran. European hematology association Congress. 6-9 Jun. 2002; Florans, Italy.
  9. 173. Karimi M, Peyvandi F, et al: Comparison of acceptability of abortion and PND procedure among hemophilic patients & parents between Iran & Italy. XXV international congress of the world Federation of Hemophilia. 19- 24 May 2002; Seville, Spain.
  10. 174. Karimi M, Ardeshiri R: Relation of coagulation disorders with ABO & RH blood groups. XXV international congress of the world Federation of Hemophilia & RH. 19- 24 May 2002; Seville, Spain.
  11. 175. F. Peyvandi, L. Tagliabue, M. Karimi and P.M. Mannucci. Characterization of nine patients with sever factor XIII deficiency. XXV international congress of the world Federation of Hemophilia & RH. 19- 24 May 2002; Seville, Spain.
  12. 176. Karimi M: Prevalence of hypoparathyroidism in b- thalassemia major patients in Shiraz – Iran. First International congress on the complications of thalassemia in Adolescents. 2-4 May 2002, Tehran, Iran.
  13. 177. Karimi M, Ghadir N: Evaluation of family planning in 510 b- thalassemia Patients parents in Shiraz – Iran. First International congress on the complications of thalassemia in Adolescents. 2 –4 May 2002, Tehran, Iran.
  14. 178. Ghavanini AA, Karimi M: Sero prevalence of viral hepatitis among multitransfered thalassemic children in Iran. 18 – 21 October 2001, Athens, Greece.
  15. 179. Karimi M, Askarinegad A, Farahmand – beigi M, et al: Regional mapping of the prevalence of b- thalassemia in Fars province. 14th international congress of Geographic Medicine. 5 – 8 Nov. 2001, Shiraz, Iran.
  16. 180. Norani Kh, Zakerinia M, Ramzi M, Rahiminejad M, Shahriari M, Karimi M: Bone marrow transplantation in acut myeloid leukemia. First international Iranian congress on cancer. 11- 13 Sep. 2001, Mashhad, Iran.
  17. 181.Karimi M, Ghavanini AA: Seroprevalence of HBSAg, anti HCVAb and HIV Ab among heamophilic children in Shiraz – Iran. 6 – 12 July 2001, Paris, France.
  18. 182. Karimi M, Ghavanini AA: Diabetes Mellitus in b- thalassemic patients. Conference of Diabetes in the Arab World. 24 – 26 March 2001, Bahrain, Bahrain.
  19. 183. Karimi M, Sabri MR: Survey of Cardiac System in 50 b- thalassemic patients in Shiraz. 13th international congress of geographic medicine and the congress of cardiovascular diseases. 2 – 5 October 2000, Shiraz, Iran.
  20. 184. Karimi M: Prevalence of HIV seropositive in 490 b- thalassemic patients in Shiraz, Southern of Iran. 13th international congress of geographic medicine and the congress of cardiovascular diseases. 2 – 5 October 2000, Shiraz, Iran.
  21. 185. Karimi M: The evaluation of liver functions of thalassemia major patients undergoing bone marrow transplantation. 1st course in thalassemias and sickle cell anemia in the mediterranean. 20 – 22 November 1999, Sestri lavante, Italy.
  22. 186.Karimi M: Survey and Rate determination of blood transfusion reactions in thalassemic patients referring to Dastgheib Hospital. 11th international congress of geographic medicine and the congress of ambulatory medicine. 9 – 12 October 1998, Shiraz, Iran.

 

 

 

 

 

Publications:

1.      Musallam KM, Taher AT, Karimi M, Rachmilewitz EA. Cerebral infarction in β-thalassemia intermedia: Breaking the silence. Thromb Res. 2012 Aug 2. [Epub ahead of print]

2.      Haghpanah S, Karimi M, Bordbar M, Kamfiroozi R, Asgharzadeh H. Experience on Using Prothrombin Complex Concentrate in Urgent Warfarin Reversal: An Iranian Survey. Clin Appl Thromb Hemost. 2012 Jun 25. [Epub ahead of print]

3.      Karimi M, Haghpanah S, Bagheri MH, et al. Frequency and distribution of asymptomatic brain lesions in patients with beta-thalassemia intermedia. Ann Hematol. 2012 Jul 24. [Epub ahead of print]

4.      Bordbar MR, Taj-Aldini R, Haghpanah S, Karimi M, et al.Thyroid function and stress hormones in children with stress hyperglycemia. Endocrine. 2012 Jun 2. [Epub ahead of print]

  1. 5.Ashjazadeh N, Emami S, Petramfar P, Yaghoubi E, Karimi M. Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study. Anemia. 2012:798296. Epub 2011 Dec 29.
  2. 11.Karimi M, Zekavat OR, Haghpanah S, Javad P, Karamizadeh Z. Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea. Hematology. 2012 Mar;17(2):122-4.
  3. 12.De Sanctis V, Elawwa A, Angastiniotis M, Eleftheriou A, Kattamis C, Karimi M, El Kholy M, Elsedfy H, Yassin MA, Fiscina B, Soliman AT. Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011). Pediatr Endocrinol Rev. 2012 Mar;9(3):672-9.
  4. 13.Mehramiri A, Parand S, Haghpanah S, Karimi M. Attitudes of haemophilic patients towards their health and socio-economic problems in Iran. Haemophilia. 2012 Jan;18(1):122-8.
  5. 14.Rashid M, Karimi M. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran. Transfus Med. 2012 Apr;22(2):104-7
  6. 15.Karimi M, Haghpanah S, Farhadi A, Yavarian M. Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. Int J Hematol. 2012 Jan;95(1):51-6.
  7. 16.Eshghi P, Cohan N, Lak M, Naderi M, Peyvandi F, Menegatti M, Karimi M. Arg77His and Trp187Arg are the Most Common Mutations Causing FXIII Deficiency in Iran. Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):100-3.
  8. 17.Haghpanah S, Karimi M. Cerebral thrombosis in patients with β-thalassemia: a systematic review. Blood Coagul Fibrinolysis. 2012 Apr;23(3):212-7.
  9. 18.Dehghani SJ, Amiri Dashtarzhen A, Karimi M, et al. Combined α-thalassemia and Hemoglobin J-Iran (β77 His → Asp). A Family Study in southern Iran. Iran Red Crescent Med J. 2011 Aug;13(8):586-9.
  10. 19.De Sanctis V, Soliman AT, Angastiniotis M, Eleftheriou A, Kattamis Ch, Karimi M, et al. International network on endocrine complications in thalassaemia (I-CET): an opportunity to grow. Georgian Med News. 2012 Apr;(205):52-7.
  11. 20.Karimi M, Vafafar A, Haghpanah S, et al. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran. Haemophilia. 2012 Mar;18(2):2011-215.
  12. 21.Bastani P, Pourmohamadi K, Karimi M. Quality of life in hemophilia complicated by inhibitors. Iran Red Crescent Med J. 2012 Apr;14(4):250-1.
  13. 22.Karimi M,Emadmarvasti V, Hoseini J,Shoja L. Major Causes of Hospital Admission in Beta Thalassemia Major Patients in Southern Iran. IJP. 2011;21(4) : 509-513.
  14. 23.Cohan N, Karimi M. Diagnosis and Management of von Willebrand Disease in Iran. SEMIN THROMB HEMOST. 2011; (5):602-13.
  15. 24.Karimi M & Cohan N. B-thalassemia Intermedia, a review of literature. IJBC. 2011;4:179-187.
  16. 25.Rasekh HR, Imani A, Karimi M, Golestani M. Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran. Clinicoecon Outcomes Res. 2011;3:207-12.
    1. 26.Kiadaliri A, Bastani P, Karimi M, et al. The Impact of Factor VIII Inhibitors on Factor Consumption in Haemophilia A: A Case-Control Study in South of Iran. Middle East Journal of Scientific Research. 2011;8(3): 694-98.
    2. 27.Karimi M, Musallam Kh, Cappellini M, et al. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia. European Journal of Internal Medicine. 2011; 22: 607–610.
    3. 29.Hashemi F, Asadi N, Beheshtipour N, Karimi M. The Impact of Educating Parents of Leukemic Children on the Patients’Quality of Life. Iran Red Crescent Med J. 2011; 13(8):553-7.
    4. 30.Basiratnia M, Yavarian M, Karimi M, et al. Non-Hodgkin Lymphoma in a Child with Schimke Immuno-Osseous Dysplasia. Iran J Med Sci September 2011; 36 (3): 222-5.
    5. 31.Amoozgar H, Farhani N, Karimi M. Risk factors for pulmonary hypertension in patients with thalassemia intermedia. European Journal of Haematology. 2011; 85 :549-551
    6. 32.Karimi M, Ravanbod S, Cohan N, Ala F. How to deal with medical and social aspects of bleeding disorders--preparing women and the family in developing countries. Haemophilia. 2011 Jul; 17 Suppl 1:42-4.
  17. 33.Haghpanah S, Vafafar M, Karimi M, et al. Use of Glubran 2 and Glubran tissue skin adhesive in patients with hereditary bleeding disorders undergoing circumcision and dental extraction. Ann Hematol. 2011; 90:463–468.
    1. 34.Amoozgar H, Farhani N, Karimi M. Early echocardiographic findings in b-thalassemia intermedia patients using standard and tissue Doppler methods. Pediatr Cardiol. 2011; 32:154-159.
    2. 35.Cohan N, Sarikhani S, Moslemi S, Karimi M. Initial presentation of acute lymphoblastic leukemia with osteoporosis and multiple spontaneous bone fractures. Iran Red Crescent Med J 2011:13(1):52-54
    3. 36.Karimi M, Emad Marvasti V, Imanieh MH, Jahaniar Moqadam F. Amantadine plus interreron-a versus interferon-a monotherapy for the treatment of chronic hepatitis C infection in b-thalassemia major patients: a randomized double blinded pilot study in Shiraz, Iran. Iranian Journal of Blood and Cancer Vol 2 No 1 Autumn 2009, 19-23
    4. 37.Shamsakhzari Sh, Afrasiabi AB, Haghpanah S , Karimi M. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease in southern Iran. Blood Coagul Fibrinolysis. 2011 Jun; 22(4):325-30.
    5. 38.Jenabali Jahromi B, Karimi M. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia 2011; 17, 703–20.
    6. 39.Rezaeifarid M, Soveid M, Ghaemi S, Karimi M. Bone mineral density in Iranian patients with hemophilia: the first experience in southern Iran. Haemophilia. 2011 May;17(3):552-3.

6.      Naderi M, Eshghi P, Cohan N, Karimi M et al. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia. 2012 Sep;18(5):773-776.

7.      Bazrgar M, Karimi M. Is Apolipoprotein E E4 Allele Always Hazardous? Serum Uric Acid Level as a Conflict. Genet Test Mol Biomarkers. 2012 Aug;16(8):920-3.

8.      Haghpanah S, Nasirabadi Sh, Karimi M, et al. Polymorphisms Associated with Sickle Cell Disease in Southern Iran. Russian Journal of Genetics. 2012; 48:755–757.

9.      Taher AT, Musallam KM, Karimi M, Cappellini MD. Contemporary approaches to treatment of beta-thalassemia intermedia. Blood Rev. 2012 Apr;26 Suppl 1:S24-7.

10.  Bordbar M, Haghpanah S, Afrasiabi A, Dehbozorgian J, Karimi M. Genotype-phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran. J Clin Lipidol. 2012 Mar;6(2):108-13.

  1. Pishva N, Afrasiabi A, ShahbaziMR, Karimi M, HaghpanahS. Protein C concentration in newborn infants with sepsis-like illness. Journal of Neonatal-Perinatal Medicine 4 (2011) 55–58.
  1. Haghpanah S, Sahraiian M, Afrasiabi A.R, Enayati S, Karimi M. The correlation between gene mutations and inhibitor development in patients with hemophilia A in southern Iran.      

Haemophilia 2011; 17:815–829.

  1. 41.Rezazadeh S, Haghighat A, Mahmoodi M, Babanezhad Z, Karimi M. Synoviorthesis induced by Rifampicin in hemophilic arthropathy; Report of 24 treated joints. Annals of Hematology. 2011, 90:963–969.
  2. 42.Alyasin S, Moghtaderi M, Karimi M, et al. Pulmonary function test in transfusion-dependent β-thalassemia major patients: a pilot study. Pediatr Hematol Oncol. 2011 May; 28(4):329-33.
  3. 43.Yavarian M, Cohan N, Karimi M, et al. Impact of Iron deficiency anaemia on HbA2 levels. Journal of Appplied Hematology. 2011; 200-2.45.Yavarian M, Ramzi M, karimi M, et al. Impact of inherited thrombophilic factors on deep vein thrombosis in individuals in south Iran. Journal of Applied Hematology 2011, 15-19.
    1. 44.Mahmoodi M, Peyvandi F, Afrasiabi A.R, Ghaffarpasand F, Karimi M. Bleeding Symptoms in Heterozygous Carriers of Inherited Coagulation Disorders in Southern Iran. Blood Coagulation and Fybrynolyisis. 2011, Vol 22 No 5.
  4. 46.Mahdavi MR, Karimi M, Yavarian M, et al. Detection of Hb Setif in north Iran and the question of its origin: Iranian or multiethnic? Hemoglobin. 2011;35(2):152-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  5. 49.16. Amooee S, Samsami A, Jahanbakhsh J, Karimi M. The pregnancy outcome in patients with minor beta-thalassemia. IJRM 2011; 9(1): 9-14.
  1. Hassanzadeh J, Mohammadi R, Rajaeefard A.R, Bordbar M.R, Karimi M. Maternal and Prenatal Risk Factors for Childhood Leukemia in Southern of Iran. IRCMJ 2011;13(6):1-6.
  2. Mahmoodi M, De Sanctis V, Karimi M.Diffuse Intracerebral Calcification in a Beta-Thalassaemia Major Patient withHypoparathyroidism: A Case Report. Pediatric Endocrinology Reviews 2011; 8 (Sup 2):331-3.
  1. De Sanctis V, Giovannini M, Ciccone S, Karimi M.Generalized Tonic-Clonic Seizures

       in a Thalassemic Patient with Hypoparathyroidism and Brain Calcinosis. Pediatric

       Endocrinology Reviews 2011; 8(sup 2):334-6.

  1. 51.Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi Ghiam A, Karimi M. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in Southern Iran. Pathol. Oncol. Res. (2010) 16:579-582
  2. 52.Bazrgar M, Peiravian F, Abedpour F, Karimi M. Causes for hospitalization and death in Iranian patients with β-thalassemia major. Pediatr Hematol Oncol. 2011 Mar;28(2):134-9.
  3. 53.Shahriari M, Bordbar M.R, Geramizadeh B, Karimi M. Leukemic infiltration of the appendix as an unusal site of extramedulary relapse: reportof of two cases and review of the literature. IJMS Vol 35, Sep. 2010
  4. 54.Karimi M, Mehrabani D, Pasalar M, Afrasiabi AR, Mehravar Z, et al. Thalassemia, iron and G6PD deficiency in lor migrating nomad children, Southern Iran. IRCMJ 2010;12(4):441-445
  5. 55.De Sanctis V, Ciccone S, Karimi M. Generalized tonic-clonic seizures in a thalassemic patient with hypoparathyroidism and brain calcinosis. Rivista Italian di Medicina dell' Adolescenza - Volume 8, n. 2, 2010
  6. 56.Faramarzi A, Karimi M, Heydari S.T, et al. Frequency of sensory neural hearing loss in major beta-thalassemias in Southern Iran. Iran J Pediatr, Sep 2010;Vol 20 (No 3), 308-312
  7. 57.Karimi M, Khanlari M, Rachmilewits EA. Erratum: "Cerebrovascular accident in b-thalassemia major (b-TM) and b-thalassemia intermedia (b-TI)" by Karimi et al. Am J Hematol 83:77-79, 2008, DOI number 20938. Am J Hematol. 2010 Sep 14.
  8. 58.Taher AT, Masullam KM, Karimi M, et al. Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010; Jun 7.
  9. 59.Taher AT, Musallam KM, El-Beshlawy A, Karimi M, et al. Age-related complications in treatment-naïve patients with thalassemia intermedia. Br J Haematol. 2010Aug;150(4):486-9.
  10. 60.Haghpanah S, Davani M, Samadi B, Ashrafi A, Karimi M. Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran. JRMS/May & June 2010;Vol 15, No 3
  11. 61.Karimi M, Emad Marvasti V, Rasekhi A, et al. MRI evaluation of liver iron concentration in patients with β-thalassemia major. Hepatitis Monthly 2010; 10(2):149-150.
  12. 62.Karimi M, Cohan N. Cancer-associated thrombosis. The Open Cardiovascular Medicine Journal, 2010, 4, 59-63.
  13. 63.Karimi M, Bagheri H, Rastgu F, et al. Magnetic resonance imaging to determine the incidence of brain ischemia in patients with β-thalassemia intermedia. Thrombosis and Haemostasis 103.5/2010
  14. 64.Akbari A, Dehbozorgian J, Afrasiabi A.R., Gafari H, Gerdabi J, Karimi M. Frequnecy of afterload homocysteinemia in normal population of southern Iran: A pilot study. Pakistan Journal of Biological Sciences 13(7):352-354,2010
  15. 65.Zareifar S, Bordbar MR, Karimi M, Geramizadeh B, Rasekhi AR. T-cell lymphoblastic lymphoma of the sternum. J Clin Oncol. 2010 Feb 1;28(4):e51-3.
  16. 66.Fotouhi Ghiam A, Hashemi A, Taban S, Bordbar M.R, Karimi M. Beta thalassemia minor as a risk factor for suicide and violence: A failure to replicate. Pshychology, 2010,1:17-21
  17. 67.Eshghi P, Mahdavi M, Karimi M, Aghighi M. Haemophilia in the developing countries: the Iranian experience. Arch Med Sci 2010; 6, 1: 83-89.
  18. 68.Karimi M, Johari S, Cohan N. Attitude toward prenatal diagnosis for beta-thalassemia major and medical abortion in Southern Iran. Hemoglobin. 2010; 34(1):49-54.
  19. 69.Karimi M, Cohan N, Moosavizadeh K, Falahi MJ, Haghpanah S. Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience. Pediatr Hematol Oncol. 2010 Apr;27(3):205-11.
  20. 70.Karimi M, Haghpanah S, Amirhakimi A, Afrasiabi AR, et al. Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory. Blood Coagulation and Fibrinolysis 2009,20:642-645
  21. 71.Karimi M, Afrasiabi A, Amoei S, et al. Goagulation disorder in women with idiopathic menorrhagia. APJOH 2010;2(1), February.
  22. 72.Taher AT, Musallam KM, Karimi M, El-Beshlawy A, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication-rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2009 Dec 23.
  23. 73.Rashid M, Majid OB, Dehghani M, Karimi M. Normal hemoglobin and hematological indices in Southwest of Iran. IJBC Vol 1, No 3, Spring 2009, 99-101.
  24. 74.Yavarian M, Shahian M, Karimi M, Rezaie N. Prevalence of pyruvate kinase deficiency among the newborns (Shiraz-Iran). IJBC Vol 1, No 3, Spring 2009, 89-93.
  25. 75.Yavarian M, Karimi M, Paran F, et al. Multi centric origin of Hb D-Punjab [beta 121 (CH4) Glu--> Gln, GAA>CAA]. Hemoglobin. 2009,33(6):399-405.
  26. 76.Eshghi P, Mahjour SB, Naderi M, Dehbozorgian J, Karimi M. Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran. Haemophilia. 2009 Oct 29.
  27. 77.Yavarian M, Saberfiroozi M, Mehrabani D, Amirizadeh S, Karimi M. Prevalence of the HFE gene mutation in the liver transplanted and primary hemochromatosis patients in the Southern Iran. IRCMJ 2010;12(1):22-26.
  28. 78.Zekavat OR, Mohammadi Samani S, Nasibi S, Karimi M. Clinical evaluation of the new topical anesthetic formulation in β-thalassemia major patients. The Journal of Applied Research Vol. 9, No. 3, 2009.
  29. 79.Karimi M, Cohan N, Zareifar S, et al. Initial presentation of childhood keukemia with facial palsy: three case reports. BMJcasereports 2009; Dec.
  30. 80.Taban S, Fotouhi Ghiam A, Mosallaei A, Bordbar MR, Mannucci PM, Karimi M. Frequency of antiphosholipid antibodies in Iranian patients with solid malignancies: a pilot study. Iran J Immunol. 2009 Sep;6(3):160-2.
  31. 81.Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S. Effect of combination therapy of hydroxyurea with L- carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. Eur J Haematol. 2009 Oct 3.
  32. 90.Mehrabani D, Pasalar M, Afrasiabi A.R, Mehravar Z, Reyhani I, Hamidi R, Karimi M. Frequency of thalassemia, Iron and Glucose-6-phosphate dehydrogenase deficiency among Turkish migrating nomad children in southern Iran. Acta Medica Iranica. 2009;Vol 47, No.1, 20-24
  33. 91.Zekavat OR, Karimi M, Rahmanian F. Is red cell from an otherwise healthy G6PD-deficient donor efficient for transfusion to fauvism patients? Indian J Hematol Blood Transfus. 2009 March;25(1):23-26
  34. 92.Rasekhi AR, Naderifar M, Bagheri MH, Shahriari M, Foroutan H, Karimi M, et al. Radiofrequency ablation of the spleen in patients with thalasemia intermedia: a pilot study. AJR Am J Roentgenol. 2009 May; 192(5):1425-9
  35. 93.Palla R, Lavoretano S, Lombardi R, Garagiola I, Karimi M, et al. The first detection mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura. Haematologica. 2009 Feb;94(2):289-93
  36. 94.Karimi M, Haghighat M, Moemen T, Jamalian N. Prevalence of Helicobacter pylori -associated peptic lesions among patients with sickle cell disease with recurrent abdominalpain. Indian J Gastroenterol. 2008 Sep-Oct;27(5):213-4.
  37. 95.Karimi M, Bonyadi M, Galehdari MR, Zareifar S. Termination of pregnancy due to Thalassemia major, Hemophilia, and Down's Syndrome: the views of Iranian physicians. BMC Med Ethics. 2008 Dec 23;9(1):19.
  38. 96.Karimi M, Borzouee M, Mehrabani A, Cohan N. Echocardiographic finding in beta-thalassemia intermedia and major: Absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. Eur J Haematol. 2008 Dec 5.
  39. 97.Jafari H, Lahsaeizadeh S, Jafari P, Karimi M. Quality of life in thalassemia major: reliability and validity of the Persian version of the SF-36 questionnaire. J Postgrad Med. 2008 Oct-Dec;54(4):273-5
  40. 98.Karimi M, Cohan N, Bagheri MH, Lotfi M, Omidvari Sh, Gramizdeh B. A lump on the haead. Lancet vol 372 October 18 2008:1436
  41. 99.Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in beta-thalassemia major: Stimulated phenotype versus suppressed activity. Ann Hematol. 2009 Jan;88(1):21-7.
  42. 100.Karamifar H, Karimi M, Sobhani N. Insulin-like growth factor-1 levels in children with Beta-thalassemia minor. Turkish Journal of Hematology. September 2008:Vol 25 Issue 3 136-139
  43. 101.Karimi M, Jafari H, Lahsaeizadeh S, Afrasiabi A, Akbari A, Dehbozorgian J, Ardeshiri R, et al. Factor XI deficiency in Southern Iran: identification of a novel missense mutation. Ann Hematol DOI 10.1007/s00277-2008:595-4
  44. 102.Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani M.T, Chung D.W, Ferrari S, Fujimura Y, Karimi M, et al. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13). Journal of Thrombosis and Hemostasis, 2008 (6): 1534-1541
  45. 103.Gharagozloo M, Karimi M, Amirghofran Z. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity. Ann Hematol. 2008 Aug 9
  46. 104.Karimi M, Mehrabani D, Yarmohammadi H, Safaei Jahromi F. The prevalence of signs and symptoms of childhood leukemia andlymphoma in Fars Province, Southern Iran. Cancer Detection and Prevention 32 (2008) 178–183
  47. 105.Karimi M. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath. Semin Hematol. 2008
  48. 106.Karimi M, Karamizadeh Z, Lahsaeizadeh S, Jafari H, Mavali Y, De Sanctis V. Prevalence of diabetic ketoacidosis (DKA) in thalassemia major patients in Iran due to secondary iron overload. Rivista Italiana di Medicina dell' Adolescenza – Volume 6, n. 1, April 2008, 47-51.
  49. 107.Karimi M, Lahsaeizadeh S, Jafari H, Salami Z. Evaluation of prevalence of drug dependence in beta-thalassemic patients and its risk factors. Journal of substance Use. 2008, March; 18 (44 31), 1-6.
  50. 108.Karimi M, Borhani Haghighi A, Yazdani M, Raisi H, Giti R, Namazee MR. Is b-thalassemia trait a protective factor against ischemic, cerebrovascular accidents? Journal of stroke and cerebrovascular diseases, Vol 17, No. 2,(March-April), 2008: 79-81
  51. 109.Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital Factor X deficiency. Haematologica. 2008 Apr 9.
  52. 110.Karimi M, Shafieian R. Prophylactic effect of recombinant factor VIIa in two patients with congenital factor VII deficiency. Haemophilia. 2008 Apr 9.
  53. 111.Karimi M, Rahmani S, Ardeshiri R, Pasalar M. Health status in Iranian haemophilic patients. Haemophilia. 2008 Apr 3.
  54. 112.Karimi M, Jamalian N. Sociocultural challenges of thalassemia birth in islamic and developing countries. J Pediatr Hematol Oncol, 2008 Apr; 30(4):335.
  55. 113.Derakhshan A, Karimi M, Ghadimi Moghadam A. Comparative evaluation of renal findings in Beta-thalassemia major and intermedia. Saudi J Kedney Dis Transpl 2008;19(2):206-209.
  56. 114.Kashef S, Karimi M, Amirghofran Z, Ayatollahi M, et al. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int. Jnl. Lab. Hem. 2008,30,11-16.
  57. 115.Peyvandi F, Lavoretano S, Palla R, Feys H.B, Vanhoorelbeke K, Battaglioli T, Valsecchi C, Canciani M.T, Fabris F, Zver S, Reti M, Mikovic D, Karimi M, et al. Adamts13 and anti-adamts13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica 2008 Feb;93(2):232-9
  58. 116.Karimi M, Yavarian M, Afrasiabi A, Dehbozorgian J, Rachmilewitz E. Prevalence of beta-Thalassemia Trait and Glucose-6-Phosphate Dehydrogenase Deficiency in Iranian Jews. Arch Med Res. 2008 Feb;39(2):212-4.
  59. 117.Inaloo S, Karimi M. Facial palsy as first presentation of acute lymphoblastic leukemia: A case report. Iran J Child Neurology. 2007 Nov;2(1):51-53
  60. 118.Karimi M, Bagheri MH, Tahmtan M, Shakibafard A, Rashid M. Prevalence of hepatosplenomegaly in beta thalassemia minor subjects in Iran. Eur J Radiol. 2007 Oct 26.
  61. 119.Yavarian M, Karimi M, Shahriary M, Afrasiabi AR. Prevalence of pyruvate kinase deficiency among the south Iranian population: Quantitative assay and molecular analysis.Blood Cells Mol Dis. 2007 Oct 30.
  62. 120.Kadivar MR, Ghaneh-Shirazi R, Khavandegaran F, Karimi M. Epidemiology of tuberculosis among Afghan immigrants in Fars province, Southern Islamic Republic of Iran. East Mediter Health J. 2007 Jul-Aug; 13(4):758-64.
  63. 121.Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh Z. RBC alloimmunization in blood transfusion dependent beta-thalassemia patients in Southern Iran. Int J Lab Hematol. 2007 Oct; 29(5):321-6
  64. 122.Afrasiabi A, Lecchi A, Artoni A, Karimi M, Ashouri E, Peyvandi F, Mannucci PM. Genetic characterization of patients with Bernard-Soulier syndrome and their relatives from Southern Iran. Platelets. 2007 Sep; 18(6):409-13
  65. 123.Karimi M, Khanlari M, Rachmilewitz EA. Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). Am J Hematol. 2007 Aug 15.
  66. 124.Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaee A, Saadat M. Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep. 2007 Jun 27.
  67. 125.Karimi M. Bone mineral density and thalassemia-reply. Indian Pediatr. 2007 Jul; 44(7):550
  68. 126.Karimi M, Borhani Haghighi A, Raisi H, Yazdani M, Namazi MR. Is b-thalassemia trait a protective factor against ischemic cerebrovascular attacks? Scientific Medical Journal. Ahwaz Jundishapur University of Medical Sciences. Winter 2007;51 (4-5):753-756
  69. 127.Sabzi A, Karimi M. A 13-year study on the prevalence and clinical features of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in patients referring hospitals to Shiraz University. Scientific Medical Journal. Ahwaz Jundishapur University of Medical Sciences. 2007 Spring; 52(1-6):16-24
  70. 128.Akbari A, Imanieh MH, Karimi M, Tabatabaee HR. Hepatitis C virus antibody positive cases in multitransfused thalassemic patients in South of Iran. Hepatitis Monthly 2007; 7(2): 63-66
  71. 129.Karimi M, Hashemi A, Ghiam AF, Jahromi SS, Toobaee S. Substance dependency in Iranian patients with hemophilia. Addict Behav. 2007 Feb; 32(2):365-9
  72. 130.Karimi M, Rahmani S, Ardeshiri R, Rahman Attar A, Pasalar M. Cost of care in Iranian hemophilic patients. IRCMJ, 2007; 9(3):1561-4395
  73. 131.Bazrgar M, Karimi M, Peiravian F, Fathzadeh M, Fattahi MJ. Apolipoprotein E4 allele and the risk of left ventricular dysfunction in thalassemia major. Iranian Cardiovascular Research Center. 2007; 1(1):13-19
  74. 132.Foroughinia F, Karimi M. The protective effects of ginkgo biloba extract in decreasing hemolysis of RBC in glucose-6-phosphate dehydrogenase-deficient patients. J Pediatr Hematol Oncol. 2007 Jul; 29(7):511-512
  75. 133.Karimi M, Jamalian N, Rasekhi A, Kashef S. Magnetic resonance imaging (MRI) findings of joints in young b-thalassemia major patients. Fluid surrounding the scaphoid bone. J Pediatr Hematol Oncol 2007 June; 29(6):393-8
  76. 134.Monaldini L, Asselta R, Duga S, Peyvandi F, Karimi M, Malcovati M, Tenchini ML. Mutational screening of six afibrinogenemic patients: identification and characterization of four novel molecular defects. Thromb Haemost. 2007 Apr;97(4):546-51
  77. 135.Bazrgar M, Karimi M, Peiravian F, Fathzadeh M.Apolipoprotein E gene polymorphism and left ventricular function in Iranian patients with thalassemia major. Haematologica. 2007 Feb;92(2):256-7
  78. 136.Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M, Kashef S.
    Bone mineral density in beta-thalassemia major and intermedia.
    Indian Pediatr. 2007 Jan;44(1):29-32
  79. 137.Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for b-thalassemia in southern Iran: options for improving the programme. J Med Screen 2007; 14: 62-66
  80. 138.Karimi M, Yarmohammadi H, Cappellini MD. Analysis of intelligence quotient in patients with homozygous beta-thalassemia. Saudi Med J. 2006 Jul; 27(7): 982-5
  81. 139.Yavarian M, Farshidfar GR, Karimi M, Almoazzez M, Harteveld CL, Giordano PC. Survival analysis of transfusion dependent b-thalassemia major patients. J Res Health Sci. 2006; 6(2):8-13
  82. 140.Karimi M, Zekavat OR, Sharifzadeh S, Mosavizadeh K. Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray. Am J Hematol. 2006 Aug; 291(1):35-9.
  83. 141.Karimi M, Sabzi A, Peyvandi F, Mannucci P.M. Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in Southern Iran. Intern Emerg Med. 2006;1(1):35-39
  84. 142.Marvasti VE, Dastoori P, Karimi M. Is beta-thalassemia trait a risk factor for developing depression in young adults? Ann Hematol. 2006 Dec; 85(12):873-4
  85. 143.Shahian M, Zekavat O, Karimi M. Extensive thrombosis following central venous catheterization in a neonate with homozygous protein C deficiency presenting purpura fulminans. Care Rep Clin Pract Rev. 2006;7: 107-110
  86. 144.Karamifar H, Karimi M, Amirhakimi GH, Badiei M. Endocrine function in thalassemia intermedia. IJBS Vol 2, No 3, September 2006: 236-240
  87. 145.Nabavizadeh S.H, Karimi M, Amin R. Cutaneous finding in anti thymocyte globulin induced serum sickness. Iran J Allergy Asthma Immunol. 2006 March;5(1):39-40
  88. 146.Pishva N, Karimi M. A pilot study on the rate of hemoglobinopathies in hyperbilirubinemic term neonates at Nemazee hospital Shiraz, Iran. Journal of Shaheed Sadoughi University of Medical Sciences and Health Services. Winter 2006;13(5):15-18
  89. 147.Bazrgar M, Karimi M. Frequency of apolipoprotein E alleles in Iranian populations. Iranian journal of biotechnology, Vol. 4, No. 2, April 2006: 141
  90. 148.Imanieh MH, Mowla A, Zohouri D, Forootan HR, Karimi M. Spontaneous perforation of the common bile duct with eosinophilia in an 18-month-old girl: A case report and review of literature. Med Sci Monit. 2006 Mar;12(4):31-33
  91. 149.Karimi M, Sabzi A, Peyvandi E, Mannucci PM. Changing epidemiology of the hemolytic uremic syndrome and thrombotic thrombocytopenic purpura in southern Iran. J Thromb Haemost. 2006 Mar;4(3):701-2
  92. 150.Karimi M, Garagiola M.B, Sharif Kazemi S., et al. Molecular study of vascular endothelial growth factor gene in Iranian patients after myocardial infarction. IJMS. 2006 March; 31(1): 1-4
  93. 151.Kashef MA, Kashef S, Handjani F, Karimi M. Hodgking lymphoma developing in a 4.5 year-old girl with hyper-IgE syndrome. Pediatr Hematol Oncol. 2006 Jan-Feb; 23(1):59-63
  94. 152.Karimi M, Marvasti VE, Motazedian S, Sharifian M. Is beta-thalassemia trait a protective factor against hypertension in young adults? Ann Hematol. 2006 Jan; 85(1): 29-31.
  95. 153.Karimi M, Panahande A, Afrasiabi A. Evaluation of factor VI leiden and prothrombin mutations in South of Iran. Winter 2006;11(4):81-88
  96. 154.Amin A, Jalali S, Amin R, Aale-yasin S, Jamalian N, Karimi M. Evaluation of the serum levels of immunoglobulin and complement factors in b-thalassemia major patients in Southern Iran. Iranian Journal of Immunology. 2005;2(4): 221-226
  97. 155.Karimi M, Imanieh MH, Ghiam A, Hashemi Z. Investigation of helicobacter pylori infection in b-thalassemia major patients with recurrent abdominal pain. European Journal of Gastroenterology & Hepatology. 2005 Dec.;17(12):1363-7.
  98. 156.Afrasiabi A, Artoni A, Karimi M, Peygandi F, et al. Glanzmann thrombasthenia and Bernard-Soulier syndrome in South Iran. Clin Lab Hematol. 2005 Oct; 27(5):324-7.
  99. 157.Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005 Jul;27(7):380-5
  100. 158.Yavarian M, Karimi M, Zorai A, et al. Molecular basis of Hb H disease in southwest Iran. Hemoglobin. 2005; 29(1): 43-50
  101. 159.Momen T, Karimi M, Haghighat H. Role of helicobacter pylori infection in sickle cell disease with recurrent abdominal pain. Armaghane-danesh. 2005 Autumn; 10(3): 35-40
  102. 160.Asadipooya A, Karamizadeh Z, Bagheri MH, Rasekhi A, Karimi M, et al. Radiologic findings of childhood acute lymphoblastic leukemia during and after chemotherapy. Ahwaz Jundishapur University of Medical Sciences. Summer 2005; 4(2): 123-126
  103. 161.Geramizadeh B, Daneshbood Y, Karimi M. Cytology of brain metastasis of yolk sac tumor. Acta Cytol. 2005 Jan-Feb; 49(1):110-1
  104. 162.Yavarian M, Sharifi S, Harteveld Cl, Giordano PC, Karimi M. The haemoglobin O-Indonesia in South of Iran: a case report and review of literature. Haema 2005; 8(1): 129-132
  105. 163.Mowla A, Karimi M, Afrasiabi A, De Sanctis V. Prevalence of diabetes mellitus and impaired glucose tolerance in beta thalassemia patients with and without hepatitis C virus infection. Pediatric Endocrinology Reviews (Supplement). 2004 Dec; 2(2):282-4.
  106. 164.Karamifar H, Karimi M, Amirhakimi GH, et al. Reduced insulin growth factor I concentrations in iron-overloaded b thalassemic patients with normal growth hormone secretion and liver function. Pediatric Endocrinology Reviews (Supplement). 2004 Dec;2(2):   256-8.
  107. 165.Karimi M, Yavarian M, Delbini P, et al. Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous. Hematol J. 2004;5(6):524-7.
  108. 166.Enayat MS, Karimi M, Chana G, et al. Mutation analysis in f9 gene of 17 families with haemophilia B fror Iran. Haemophilia. 2004 Nov; 10(6): 751-5.
  109. 167.Castelli R, Graziadei G, Karimi M, et al. Intrathoracic masses due to extramedullary hematopoiesis. Am J Med Sci. 2004 Nov; 328(5):299-303.
  110. 168.Karimi M, Karamifar H. Short stature in Beta thalassemia minor subjects in Iran. Med Sci Monit. 2004 Oct 26; 10(11): 603-
  111. 169.Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. Haematologica. 2004 Oct; 89(10): 1172-8.
  112. 170.Karimi M, Zakerinia M, Khojasteh HN, Ramzi M, et al. Successful treatment of recombinant factor VIIa in hemorrhagic cystitis induced by cyclophosphamide in post bone marrow transplantation. J Thromb Haemost. 2004 Oct; 2(10): 1853-5.
  113. 171.Bazrgar M, Peiravian F, Karimi M, Fathzadeh M. Correlation between left ventricular dysfunction with hematological parameters and Iron chelation in b-thalassemia major. JMR. Autumn 2004; 3(1): 48-58
  114. 172.Menegatti M, Karimi M, Garagiola I, Mannucci P, et al. A rare inherited coagulation disorder: Combined homozygous factor VII and factor X deficiency. Am J Hematol. 2004 Sep; 77(1): 90-1.
  115. 173.Karimi M, Peyvandi F, Siboni S, Ardeshiri R, Gringeri A, Mannucci PM. Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy. Haemophilia. 2004 Jul; 10(4):367-9.
  116. 174.Alborzi A, Cheriki S, Karimi M, Kalani M, Aboodi B. Survey incidence rate of bacterial infection in febrile neutropenic patient (under 15) admitted in Shiraz Medical Hospital (1379-1380). Iranian Journal of Infectious Diseases and Tropical Medicine. 2004;9(24):6-9.
  117. 175.Asadi-pooya AA, Karimi M, Imanieh MH. Growth retardation in children with thalassemia major. Haema 2004; 7(4): 493-496.
  118. 176.Alavi M, Nabavizadeh A, Mowla A, Karmi M. Bone scintigraphy in acute lymphoblastic leukemia. IJMS. 2004 June;29(2),14-16.
  119. 177.Karimi M, Mosallanejad L, Abdolahifard M. Liver enzyme assessment in thalassemia major patients who underwent bone marrow transplantation, Shiraz 2002. JMR. Spring 2004; 2(3): 62-70
  120. 178.Peyvandi F, Tagliabue L, Menegatti M, Karimi M, Komaromi I, Katona E, Muszbek L, Mannucci PM. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat. 2004 Jan; 23(1):98.
  121. 179.Asadipooya S, Karamizadeh Z, Rahiminejad MR, Shahriari M, Karimi M. Calcium metabolism disorders in childhood acute lymphoblastic lymphoma, before and after chemotherapy. Iranian Journal of Endocrine and metabolism. 2003;5(2):211-214.
  122. 180.Pasalar M, Mojarrab M, Rasekhi AR, Afrasiabi A, Yazdanpanah F, Karimi M. Childhood Neuroblastoma: A 10-Years Study (1991-2001). Journal of Medical Research. 2003;1(4):25-33.
  123. 181.Rahimi Z, Karimi M, Haghshenass M, Merat M. b-Globin gene cluster haplotypes in sickle cell patients from Southwest Iran. American Journal of Hematology. 2003;74:156-160
  124. 182. Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracerebral calcification in patients with beta-thalassemia major. J Pediatr Endocirinol Metab 2003 Jul-Aug; 16 (6): 883-6
  125. 183. Karimi M, Yarmohammadi H. Seasonal variation in the onset of childhood leukemia /lymphoma, 1996 to March 2000, Shiraz, Iran. Hematol Oncol. 2003 Jun; 21 (2):51-5
  126. 184. Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica. 2003 Apr; 88(4): 454-8
  127. 185. Karimi M, Martinez Di Montemuros F, Danielli MG, Farjadian S, Afrasiabi A, Fiorelli G, Cappellini MD. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran. Haematologica, 2003 Mar; 88(3): 346-7.
  128. 186. Kadivar MR, Yarmohammadi H, Mirahmadizadeh AR, Vakili M, Karimi M. Prevalence of iron deficiency anemia in 6 months to 5 years old children in Southern Iran. Med Sci Monit. 2003 Feb; 9(2): 100-4.
  129. 187. Karimi M, Yarmohammadi H, Sabri MR. An analysis of prognostic factors and the five-year survival rate in children with lymphoblastic leukemia. Med Sci Monit. 2002 Dec; 8(12): 792-6.
  130. 188. Payvandi F, Spreafico M, Karimi M, Zeinali S, Mannucch PM. Allele frequency of CYP2C9 polymorphisms in Iran. Thromb Haemost 2002;88:874-5
  131. 189. Karimi M, Rasekhi AR. Efficiency of premarital screening of beta- thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia (Budap) 2002;32(2):129-33
  132. 190. Karimi M, Yarmohammadi H, Ardeshiri R. Inherited coagulation disorders in Southern Iran. Haemophilia 2002 Nov; 8(6):740-4
  133. 191. Kumar PV, Karimi M, Monabbati A, et al.: A cytologic study of leukemic lymphadenopathy. Acta Cytol 2002 Sep-Oct;46(5):801-7
  134. 192.Karimi A, Nategian A, Karimi M, Shirvani B. Correlation between acute phase inflammation markers with cardiac complications in patients with Kawasaki disease. Journal of Hamedan University of Medical Sciences. Autumn 2002; 9(3): 17-21
  135. 193. Karimi M, Asadipooya A, Khademi B, et al: Evaluation of the incidence of sensory – neural hearing loss in Beta – thalassemia major patients under regular chelation therapy with desferrioxamine. Acta Haematol. 2002;108(2):79-83.
  136. 194. Karimi M, Yarmohammadi H, Ghavanini A, Kumar P. Epidemiological surveillance of pediatric Hodgkin s disease in Southern Iran. Med Sci Monit. 2002 Aug;8(8):572-5
  137. 195. Kumar PV, Moosavi A, Karimi M, Bedayat GR: FNA study of langerhans cell histiocytosis (Eosinophilic Granuloma) of lymph nodes: A report of six cases. Acta Cytol. 2002 Jul-Aug;46(4):753-6
  138. 196. Karimi M, Yarmohammadi H, Zeinali S, et al: Beta thalassemia intermedia from Southern Iran: IVS- II- I (G® A) is the prevalent thalassemia intermedia Allele. Hemoglobin 2002 May;26(2):147-54
  139. 197. Karimi M, Kadivar R, Yarmohammadi H. Assessment of the prevalence of iron deficiency anemia, by serum ferritin, in pregnant women of Southern Iran. Med Sci Monit 2002 Jul;8(7):488-92
  140. 198. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused children in Shiraz – Iran. J Pediatr Child Health 2001 Dec;37(6):564-6
  141. 199. Karimi M, Ghavanini AA: Seroprevalence of HBSAg, anti- HCV, and anti – HIV among haemophilia in Shiraz – Iran. Haematologica (Budap). 2001; 31(3): 251 – 5
  142. 200. Kumar PV, Moosavi A, Karimi M, et al.: Subclassification of Localized leishmania lymphadenitis in FNA semears. Acta Cytologica, 2001 Jul - Aug; 45 (4): 547 – 54
  143. 201. Karimi M, Ghavanini AA, Kadivar MR: Regional mapping of the gene frequency of b- thalassemia in Fars Province, Iran during 1997 – 1998. Irn J Med Sci 2000; 25 (3&4): 134 – 137
  144. 202. Pedram M, Zandian KM, Kiekhaie B, Mosawai F, Karimi M: Children clinical oncology emergency with 14 case reports of vencava and mediastinum syndromes in Ahwaz. Scientific Med J Ahwaz Univ Med Sci 1998; 23: 69 – 83
  1. Roozbeh J, Sharifian M, Karimi M, Hamidian Jahromi AR, Afshariani R. Effect of zinc supplementation on red blood cell osmotic fragility in hemodialysis patients. Shiraz E Medical Journal. 2009 Oct; Vol. 10, No. 4
  2. Karimi M, Haghpanah S, Amirhakimi A, Afrasiabi A, Dehbozorgian J, Nasirabady S. Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory. Blood Coagul Fibrinolysis.2009 Aug 25.
  3. Lotfi M, Keramati P, Assdsangabi R, Nabavizadeh SA, Karimi M. Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran.Med Sci Monit. 2009 Aug;15(8):CR398-402
  4. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb hemost. 2009 Jun;35(4):426-38
  5. Geramizadeh B, Banani A, Foroutan H, Aminsharifi A, Karimi M. Malignant epithelioid hemangioendothelioma of the bladder: the first case report in a child. J Pediatr Surg. 2009 Jul;44(7):1443-5
  6. Karimi M, Giti R, Haghpanah S, Azarkeivan A, Hoofar H, Eslami M. Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: A multicenter study in Iran. Pediatr Blood Cacer. 2009, Dec.
  7. Beheshtipour N, Cohan N, Karimi M.Home therapy and the effect of educational programmes in Iran; an alternative treatment option in developing countries. Haemophilia. 2009 May 19.
  8. Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. Fundam Clin Pharmacol. 2009 Jun;23(3):359-65.